Written and maintained by CASRAI Editorial Board
Last updated
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is an international non-profit scientific organisation that supports clinical microbiologists, infectious disease physicians, and epidemiologists through research networks, clinical practice guidelines, and educational programmes. Headquartered in Basel, Switzerland, ESCMID serves as a central European forum for advancing infectious disease surveillance, antimicrobial resistance research, and infection prevention. Researchers in epidemiology and related disciplines interact with ESCMID to participate in specialised Study Groups, publish in high-impact journals, and establish standardized clinical breakpoints.
What ESCMID Is
Established as an international professional organisation, ESCMID coordinates multinational scientific collaboration across clinical microbiology, infectious diseases, and hospital hygiene. The organisation champions medical progress in infection science by connecting investigators, clinicians, and laboratory scientists worldwide. Rather than acting as a laboratory bench facility or direct healthcare provider, ESCMID functions as an umbrella professional platform that structures research standards, disseminates epidemiological findings, and funds early-career scientific development.
For investigators working at the intersection of epidemiology and public health, ESCMID provides scientific infrastructure through expert committees, international surveillance initiatives, and consensus guideline panels. Its work spans infectious pathogen biology, molecular epidemiology, host-pathogen interactions, and global antimicrobial resistance monitoring.
Who Runs It and What It Covers
ESCMID is governed by an elected Executive Committee composed of clinical microbiologists and infectious disease specialists, supported by an administrative headquarters located in Basel, Switzerland. Operational activities are coordinated through standing subcommittees, advisory boards, and scientific panels dedicated to specific priorities such as emerging infections, antimicrobial resistance, and professional parity.
The scientific scope of ESCMID is structured around five core pillars:
- ESCMID Study Groups (SGs): More than 30 specialized scientific working groups focus on specific pathogen classes, clinical syndromes, or methodological domains. Key groups active in epidemiology and surveillance include the Study Group for Antimicrobial Resistance Surveillance (ESGARS), the Study Group for Epidemiological Markers (ESGEM), the Study Group for Public Health Microbiology (ESGPHM), the Study Group for Respiratory Viruses (ESGREV), and the Study Group for Genomic and Molecular Diagnostics (ESGMD).
- Clinical Practice Guidelines: ESCMID develops and publishes evidence-based clinical guidance documents and consensus statements. Guideline panels adhere to transparent operational procedures, assisted by an Evidence Review Group (ERG) that conducts systematic evidence appraisal and data extraction under strict conflict-of-interest policies.
- EUCAST Partnership: Together with the European Centre for Disease Prevention and Control (ECDC) and national breakpoint committees, ESCMID co-organises the European Committee on Antimicrobial Susceptibility Testing (EUCAST), which defines clinical breakpoints and standardized antimicrobial susceptibility testing protocols worldwide.
- Scientific Journals: ESCMID publishes Clinical Microbiology and Infection (CMI), a monthly peer-reviewed journal with an impact factor of 8.7, alongside its open-access companion title CMI Communications and the audio forum Communicable.
- ESCMID Global Congress: Formerly known as the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), ESCMID Global is the society’s annual flagship congress, convening researchers to present peer-reviewed abstracts and late-breaking clinical trials.
How Researchers Participate and Access Resources
Researchers in clinical microbiology and infectious disease epidemiology can access and participate in ESCMID programmes through structured pathways:
- Society Membership: Investigators and trainees register for membership through the ESCMID portal, with tiered dues for full members, young scientists, retired professionals, and researchers residing in low- and middle-income countries (LMICs).
- Joining Study Groups: Active ESCMID members can join any of the specialized Study Groups at no additional cost. Members participate in monthly webinars, collaborate on multicentre research protocols, and apply for SG-sponsored conference attendance grants.
- Submitting Original Research: Epidemiologists submit original research abstracts to ESCMID Global for oral presentation or poster display. Investigators tracking outbreak dynamics, such as modeling an epidemic curve or testing surveillance algorithms, regularly share data through congress sessions and publish full manuscripts in CMI or CMI Communications.
- Applying for Research Grants: ESCMID offers annual research grants to support innovative investigative projects in clinical microbiology and infectious diseases, with dedicated funding allocations for early-career investigators.
- Accessing Methodological Guidelines and Breakpoints: Guidelines and EUCAST breakpoint tables are openly published online without paywalls, allowing hospital laboratories and academic research groups to harmonize antimicrobial susceptibility testing and diagnostic protocols.
Strengths and Limits
Understanding the capabilities and structural boundaries of ESCMID helps research teams leverage the platform appropriately in their scientific workflows.
Strengths:
- Global Standardization via EUCAST: Through EUCAST, ESCMID provides authoritative, freely available antimicrobial susceptibility testing standards adopted by clinical laboratories and surveillance networks across Europe and internationally.
- Multidisciplinary Community: Study Groups bridge the traditional division between laboratory microbiologists, clinical physicians, and methodologists trained in biostatistics and epidemiology.
- Evidence Review Integrity: The inclusion of a trained Evidence Review Group (ERG) ensures that guideline recommendations follow systematic evaluation and minimize panel bias.
- Open Access Dissemination: Clinical practice guidelines, EUCAST breakpoint tables, and CMI Communications articles are published with open access.
Limits:
- Not a Regulatory Agency: ESCMID publishes clinical guidelines and scientific consensus, but it possesses no regulatory or enforcement authority; national health agencies and regulatory bodies determine local policy.
- European Orientation: Although membership and conference attendance are global, the society’s governance structures and standard-setting initiatives prioritize European healthcare systems and microbiological reference frameworks.
- Variable Grant Funding Scope: ESCMID research grants fund exploratory and seed projects; they do not replace large-scale multi-year national funding mechanisms (such as NIH or European Horizon grants).
Alternatives to ESCMID
Researchers evaluating professional societies and international platforms in infection science often consider several peer organizations:
| Organization | Primary Geographic Focus | Flagship Journal | Core Strengths and Standard-Setting Roles |
|---|---|---|---|
| ESCMID | Europe (with global membership) | Clinical Microbiology and Infection (CMI) | EUCAST antimicrobial breakpoints, ESCMID Global congress, 30+ specialized Study Groups |
| IDSA (Infectious Diseases Society of America) | United States (global membership) | Clinical Infectious Diseases (CID) | US clinical practice guidelines, IDWeek congress, antimicrobial stewardship frameworks |
| ASM (American Society for Microbiology) | United States (global membership) | Journal of Clinical Microbiology (JCM) | Broad basic and applied microbiology, ASM Microbe congress, CLSI breakpoint coordination |
| ISID (International Society for Infectious Diseases) | Global / Low- and Middle-Income Countries | International Journal of Infectious Diseases (IJID) | ProMED disease outbreak reporting, global surveillance capacity building in LMICs |
Frequently Asked Questions
What is ESCMID Global, and how does it relate to ECCMID?
ESCMID Global is the current official name of ESCMID’s annual scientific conference, which was previously called ECCMID (European Congress of Clinical Microbiology and Infectious Diseases). The rebrand reflects the worldwide reach of the congress, which brings together tens of thousands of clinicians, microbiologists, and epidemiologists each spring to present original research.
How does ESCMID coordinate with EUCAST?
ESCMID co-founded and co-organizes EUCAST alongside the European Centre for Disease Prevention and Control (ECDC) and European national breakpoint committees. EUCAST establishes clinical breakpoints and standardized testing methods for antimicrobial susceptibility, which are published freely and integrated into hospital laboratory workflows.
Can early-career epidemiologists join ESCMID Study Groups?
Yes. Any active member of ESCMID can join any of the society’s Study Groups without paying additional group fees. Early-career investigators can collaborate on multicentre research protocols, apply for study-group attendance grants, and participate in technical webinars.
What journals does ESCMID publish?
ESCMID publishes two main scientific journals in partnership with Elsevier: Clinical Microbiology and Infection (CMI), a monthly peer-reviewed journal focused on clinical microbiology and infection medicine, and CMI Communications, a fully open-access companion journal dedicated to translational and interdisciplinary infection science.
Sources
- ESCMID — The Society and Mission — Official society overview, governance structure, and headquarters information. Accessed 2026-11-07.
- ESCMID — Scientific Study Groups Directory — Descriptions of active Study Groups, including ESGARS, ESGEM, and ESGPHM, and member research participation rules. Accessed 2026-11-07.
- ESCMID — Clinical Practice Guidelines Programme — Guidelines operational procedures manual, Evidence Review Group structure, and methodology. Accessed 2026-11-07.
- ESCMID — Scientific Journals — Overview of Clinical Microbiology and Infection (CMI), CMI Communications, and the Communicable podcast. Accessed 2026-11-07.
- ESCMID — ESCMID Global Congress — Annual congress scope, abstract submission details, and educational programming. Accessed 2026-11-07.
- EUCAST — European Committee on Antimicrobial Susceptibility Testing — Antimicrobial breakpoint guidelines, methodology, and organizational sponsorship. Accessed 2026-11-07.
